DK0866720T3 - OB-protein til forögelse af mager kropsmasse - Google Patents
OB-protein til forögelse af mager kropsmasseInfo
- Publication number
- DK0866720T3 DK0866720T3 DK96938773T DK96938773T DK0866720T3 DK 0866720 T3 DK0866720 T3 DK 0866720T3 DK 96938773 T DK96938773 T DK 96938773T DK 96938773 T DK96938773 T DK 96938773T DK 0866720 T3 DK0866720 T3 DK 0866720T3
- Authority
- DK
- Denmark
- Prior art keywords
- protein
- body mass
- lean body
- increasing lean
- increasing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/06—Anabolic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56173295A | 1995-11-22 | 1995-11-22 | |
PCT/US1996/017718 WO1997018833A1 (en) | 1995-11-22 | 1996-11-04 | Methods of increasing lean tissue mass using ob protein compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0866720T3 true DK0866720T3 (da) | 2004-06-14 |
Family
ID=24243198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK96938773T DK0866720T3 (da) | 1995-11-22 | 1996-11-04 | OB-protein til forögelse af mager kropsmasse |
Country Status (15)
Country | Link |
---|---|
EP (3) | EP0866720B1 (ja) |
JP (2) | JP4173914B2 (ja) |
AT (2) | ATE455554T1 (ja) |
AU (3) | AU7607496A (ja) |
CA (2) | CA2358862A1 (ja) |
DE (2) | DE69638119D1 (ja) |
DK (1) | DK0866720T3 (ja) |
ES (2) | ES2217327T3 (ja) |
IL (2) | IL124442A0 (ja) |
MX (1) | MX9803992A (ja) |
NZ (3) | NZ527007A (ja) |
PT (1) | PT866720E (ja) |
SI (1) | SI0866720T1 (ja) |
WO (1) | WO1997018833A1 (ja) |
ZA (1) | ZA969605B (ja) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6001968A (en) | 1994-08-17 | 1999-12-14 | The Rockefeller University | OB polypeptides, modified forms and compositions |
US20030040467A1 (en) | 1998-06-15 | 2003-02-27 | Mary Ann Pelleymounter | Ig/ob fusions and uses thereof. |
EP0866720B1 (en) * | 1995-11-22 | 2004-02-11 | Amgen Inc., | Ob protein for increasing lean tissue mass |
US6936439B2 (en) | 1995-11-22 | 2005-08-30 | Amgen Inc. | OB fusion protein compositions and methods |
US6620413B1 (en) | 1995-12-27 | 2003-09-16 | Genentech, Inc. | OB protein-polymer chimeras |
US7074397B1 (en) | 1996-01-08 | 2006-07-11 | Genentech, Inc. | Method for enhancing proliferation or differentiation of a cell using ob protein |
US6541604B1 (en) | 1996-01-08 | 2003-04-01 | Genentech, Inc. | Leptin receptor having a WSX motif |
US20050019325A1 (en) | 1996-01-08 | 2005-01-27 | Carter Paul J. | WSX receptor agonist antibodies |
EP0877627A1 (en) * | 1996-01-25 | 1998-11-18 | Eli Lilly And Company | Obesity protein analog compounds and formulations thereof |
WO1997039767A1 (en) * | 1996-04-19 | 1997-10-30 | Zymogenetics, Inc. | Methods for inducing bone formation |
JP4175668B2 (ja) * | 1996-12-20 | 2008-11-05 | アムジエン・インコーポレーテツド | Ob融合タンパク質組成物および方法 |
JP2001507228A (ja) * | 1996-12-20 | 2001-06-05 | イーライ・リリー・アンド・カンパニー | 抗肥満タンパク質 |
US20020019352A1 (en) * | 1997-04-17 | 2002-02-14 | David N. Brems | Stable, active, human ob protein compositions and methods |
EP0950417A3 (en) | 1998-02-23 | 2000-02-23 | Pfizer Products Inc. | Treatment of skeletal disorders |
WO1999053939A1 (en) * | 1998-04-20 | 1999-10-28 | Mayo Foundation For Medical Education And Research | Treatment of osteoporosis with leptin |
US6210924B1 (en) | 1998-08-11 | 2001-04-03 | Amgen Inc. | Overexpressing cyclin D 1 in a eukaryotic cell line |
US6420339B1 (en) | 1998-10-14 | 2002-07-16 | Amgen Inc. | Site-directed dual pegylation of proteins for improved bioactivity and biocompatibility |
WO2000024418A1 (en) * | 1998-10-27 | 2000-05-04 | Eli Lilly And Company | Prevention of muscle mass loss with leptin receptor ligands |
EP1151102B1 (en) * | 1999-02-12 | 2006-04-19 | Amgen Inc. | Glycosylated leptin compositions and related methods |
US8106098B2 (en) | 1999-08-09 | 2012-01-31 | The General Hospital Corporation | Protein conjugates with a water-soluble biocompatible, biodegradable polymer |
ES2418954T3 (es) | 2001-10-22 | 2013-08-19 | Amgen, Inc. | Uso de la leptina para el tratamiento de la lipoatrofia humana y método para determinar la predisposición a dicho tratamiento |
NZ534757A (en) | 2002-03-12 | 2006-07-28 | Merck & Co Inc | Substituted amides |
US7579444B2 (en) * | 2004-06-30 | 2009-08-25 | Nektar Therapeutics Al, Corporation | Polymer-factor IX moiety conjugates |
US8394765B2 (en) | 2004-11-01 | 2013-03-12 | Amylin Pharmaceuticals Llc | Methods of treating obesity with two different anti-obesity agents |
CN101094689B (zh) | 2004-11-01 | 2013-06-12 | 安米林药品有限责任公司 | 治疗肥胖以及肥胖相关疾病和病症的方法 |
WO2008048691A2 (en) * | 2006-10-18 | 2008-04-24 | Amylin Pharmaceuticals, Inc. | Use of leptin for treating post-lipectomy ectopic fat deposition and other post-lipectomy associated disorders |
WO2009149379A2 (en) | 2008-06-05 | 2009-12-10 | Regents Of The University Of Michigan | Use of leptin for the treatment of fatty liver diseases and conditions |
ES2630031T3 (es) | 2010-09-28 | 2017-08-17 | Aegerion Pharmaceuticals, Inc. | Un polipéptido de leptina pinnípedo-humano quimérico con solubilidad aumentada |
PL2900230T3 (pl) | 2012-09-27 | 2019-02-28 | The Children's Medical Center Corporation | Związki do leczenia otyłości i sposoby ich zastosowania |
ES2709976T3 (es) | 2013-11-26 | 2019-04-22 | Childrens Medical Ct Corp | Compuestos para el tratamiento de la obesidad y procedimientos de uso de los mismos |
WO2015153933A1 (en) | 2014-04-03 | 2015-10-08 | The Children's Medical Center Corporation | Hsp90 inhibitors for the treatment of obesity and methods of use thereof |
BR112019004715A2 (pt) | 2016-09-12 | 2019-07-16 | Aegerion Pharmaceuticals Inc | métodos para detectar anticorpos neutralizantes anti-leptina |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1228925B (it) * | 1987-08-07 | 1991-07-10 | Eniricerche Spa | Procedimento per la preparazione dell'ormone della crescita umano |
DK173142B1 (da) * | 1988-08-24 | 2000-02-07 | Natinco Nv | Fremgangsmåde til forbedring af kødkvaliteten og foderomsætningseffektiviteten for grise |
US5028440A (en) * | 1990-01-30 | 1991-07-02 | Iowa State University Research Foundation, Inc. | Method of raising meat producing animals to increase lean tissue development |
JPH09503973A (ja) * | 1993-08-13 | 1997-04-22 | プッツマイスター・ヴェルク マシーネンファブリーク ゲゼルシャフト ミット ベシュレンクテル ハフツング | 大型対象物の表面を処理する方法および装置 |
US6309853B1 (en) * | 1994-08-17 | 2001-10-30 | The Rockfeller University | Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof |
GB9511935D0 (en) * | 1995-06-13 | 1995-08-09 | Smithkline Beecham Plc | Novel compound |
EP0866720B1 (en) * | 1995-11-22 | 2004-02-11 | Amgen Inc., | Ob protein for increasing lean tissue mass |
BR9612359A (pt) * | 1995-12-27 | 1999-07-13 | Genentech Inc | Derivado covalente de uma proteína ob composição polipeptídeo quimérico sequência de ácido nucleico vetor de express o replicável célula hospedeira e métodos associados aos mesmos |
JP4175668B2 (ja) * | 1996-12-20 | 2008-11-05 | アムジエン・インコーポレーテツド | Ob融合タンパク質組成物および方法 |
JP4086908B2 (ja) * | 1997-04-17 | 2008-05-14 | アムジエン・インコーポレーテツド | 安定かつ活性なヒトOBタンパク質と抗体Fc鎖とのコンジュゲートを含む組成物および方法 |
-
1996
- 1996-11-04 EP EP96938773A patent/EP0866720B1/en not_active Expired - Lifetime
- 1996-11-04 EP EP02011474A patent/EP1285664B1/en not_active Expired - Lifetime
- 1996-11-04 NZ NZ527007A patent/NZ527007A/en not_active IP Right Cessation
- 1996-11-04 CA CA002358862A patent/CA2358862A1/en not_active Abandoned
- 1996-11-04 AT AT02011474T patent/ATE455554T1/de not_active IP Right Cessation
- 1996-11-04 AU AU76074/96A patent/AU7607496A/en not_active Abandoned
- 1996-11-04 SI SI9630675T patent/SI0866720T1/xx unknown
- 1996-11-04 CA CA002236163A patent/CA2236163A1/en active Pending
- 1996-11-04 DE DE69638119T patent/DE69638119D1/de not_active Expired - Lifetime
- 1996-11-04 NZ NZ512083A patent/NZ512083A/xx not_active IP Right Cessation
- 1996-11-04 JP JP51974597A patent/JP4173914B2/ja not_active Expired - Fee Related
- 1996-11-04 EP EP98119160A patent/EP0956862A1/en not_active Withdrawn
- 1996-11-04 IL IL12444296A patent/IL124442A0/xx not_active IP Right Cessation
- 1996-11-04 AT AT96938773T patent/ATE259243T1/de active
- 1996-11-04 WO PCT/US1996/017718 patent/WO1997018833A1/en active IP Right Grant
- 1996-11-04 DK DK96938773T patent/DK0866720T3/da active
- 1996-11-04 ES ES96938773T patent/ES2217327T3/es not_active Expired - Lifetime
- 1996-11-04 DE DE69631544T patent/DE69631544T2/de not_active Expired - Lifetime
- 1996-11-04 PT PT96938773T patent/PT866720E/pt unknown
- 1996-11-04 NZ NZ511617A patent/NZ511617A/en not_active IP Right Cessation
- 1996-11-04 ES ES02011474T patent/ES2339846T3/es not_active Expired - Lifetime
- 1996-11-15 ZA ZA969605A patent/ZA969605B/xx unknown
-
1998
- 1998-05-20 MX MX9803992A patent/MX9803992A/es not_active IP Right Cessation
-
1999
- 1999-01-05 IL IL127926A patent/IL127926A/en not_active IP Right Cessation
-
2000
- 2000-06-23 AU AU42652/00A patent/AU763755B2/en not_active Ceased
- 2000-06-23 AU AU42653/00A patent/AU763769B2/en not_active Ceased
-
2001
- 2001-11-19 JP JP2001352728A patent/JP4227325B2/ja not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0866720T3 (da) | OB-protein til forögelse af mager kropsmasse | |
IL148079A0 (en) | Human ctla-4 antibodies and compositions containing the same | |
ATE378403T1 (de) | Transchromosomale transgen-nagetiere zur herstellung von humänen antikörpern | |
DK0713529T3 (da) | Vækst-/differentieringsfaktor af TGF-beta-familien | |
DE69731285D1 (de) | Langwellig fluorezierende proteine | |
EA200300464A1 (ru) | ГУМАНИЗИРОВАННОЕ АНТИТЕЛО ПРОТИВ РЕЦЕПТОРА ЛИМФОТОКСИНА-β (ВАРИАНТЫ), КОМПОЗИЦИЯ, СПОСОБ ЛЕЧЕНИЯ ИЛИ СНИЖЕНИЯ РИСКА РАЗВИТИЯ, ТЯЖЕСТИ ИЛИ ПОСЛЕДСТВИЙ НЕОПЛАЗИИ У ЧЕЛОВЕКА, ВЫДЕЛЕННАЯ НУКЛЕИНОВАЯ КИСЛОТА (ВАРИАНТЫ), КЛЕТКА КЛЕТОЧНОЙ ЛИНИИ | |
DE3750342D1 (de) | Menschliches gamma-interferon-spezifisches Rezeptorprotein, Antikörper gegen dieses Protein, Verfahren zur Herstellung dieses Proteins und dieses Antikörpers und dieses Protein und diesen Antikörper enthaltende Zusammensetzungen. | |
DK0845943T3 (da) | Nye peptider afledt fra humant heat shock protein 60 til behandling af diabetes, sammensætninger, fremgangsmåder og kits | |
DE69737651D1 (de) | Cortistatin: neuropeptide, zusammensetzungen und methoden | |
DK0638068T3 (da) | Fremgangsmåde til fremstilling af (S)-3-amino-1-substitueret-pyrrolidiner | |
DE68907635T2 (de) | Loetmaterial fuer brillengestelle und brillengestelle, bei denen dieses loetmaterial verwendet ist. | |
DE69735039D1 (de) | Acetylhydrolase des Plättchen aktivierenden Faktors, und entsprechendes Gen | |
DK0972520T3 (da) | Frysetörret sammensætning af humant, knoglemorfogenetisk protein MP52 | |
SE9803962D0 (sv) | Nucleic acid encoding a nervous tissue sodium channel | |
DK0601152T3 (da) | Osteosyntesehjælpemiddel til fiksering af knogler. | |
DE69409961T2 (de) | Triarylethylenderivate zur therapeutischen verwendung | |
ES2175842T3 (es) | Antagonistas de kv2.1. | |
AU8499501A (en) | Slo2 and slo4, novel potassium channel proteins from human brain | |
DE29709278U1 (de) | Implantatbausatz zur Befestigung von Zahnersatz und Teile desselben | |
ATE336503T1 (de) | Cyclophilin als allergen identifiziert | |
DE29519142U1 (de) | Fixationsimplantat |